Delivery Order SPE2DB20D3103-SPE2DB23FL5W4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,529.79 firm fixed-price delivery order is for Aranesp 300 MCG/0.6 ML syringes and has a completion date of January 3, 2024. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,423.84 Firm Fixed Price delivery order is for the supply of Aranesp 500 mcg/1 mL syringes, a specialty medication used to treat anemia. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.96 firm fixed-price delivery order contract is for the supply of ARANESP 300 MCG/0.6 ML SYRINGE 0.6ML, a pharmaceutical product. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,553.92 delivery order contract is for the supply of ARANESP 200 MCG/0.4 ML SYRINGE 0.4ML, a specialty medication. The contract is a Firm Fixed Price arrangement with a performance period through March 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,085.34 Firm Fixed Price delivery order is for the supply of ARANESP 60 MCG/0.3 ML SYRINGE 0.3ML, a specialty pharmaceutical product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC...
- This federal contract award, with a ceiling value of $2,845.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- The federal contract award is for the pharmaceutical product ARANESP 200 MCG/0.4 ML SYRINGE 0.4ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,237.92 firm fixed price delivery order has a completion date of June 3, 2024. This award is not a set-aside. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by defense and civilian agencies to supply a wide range of critical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,613.43 firm fixed price delivery order is for 4566198661 ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML, with a period of performance running through October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary mechanism for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $8,489.40 order is for the supply of Aranesp 200 mcg/0.4 mL syringes and has a completion date of February 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Aranesp 25 mcg/0.42 mL syringes, a specialty pharmaceutical product, with a potential value of $1,010.82. The contract type is a Firm Fixed Price Delivery Order with a completion date of December 21, 2023. The place of performance is...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FL5W4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,769.52 firm-fixed-price delivery order is for the supply of Aranesp 200 mcg/0.4 ml syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's critical role in supplying essential medical commodities, including specialty medications, vaccines, and medical devices, to federal government agencies and military healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/9/22 |